Japanese Healthtech Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

With its stock down 10% over the past week, it is easy to disregard Mbs (TSE:1401). But if you pay close attention, you...

There wouldn't be many who think SDS HOLDINGS Co.,Ltd.'s ( TSE:1711 ) price-to-sales (or "P/S") ratio of 0.7x is worth...

Key Insights Japan Eyewear Holdings' significant retail investors ownership suggests that the key decisions are...

It is hard to get excited after looking at CAICA DIGITAL's (TSE:2315) recent performance, when its stock has declined...

Secure, Inc.'s ( TSE:4264 ) price-to-earnings (or "P/E") ratio of 59.2x might make it look like a strong sell right now...

It is hard to get excited after looking at Fast AccountingLtd's (TSE:5588) recent performance, when its stock has...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

With a price-to-earnings (or "P/E") ratio of 22.9x Fukuyama Transporting Co., Ltd. ( TSE:9075 ) may be sending very...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Max Co., Ltd.'s ( TSE:6454 ) price-to-earnings (or "P/E") ratio of 21.6x might make it look like a strong sell right...

On November 12, 2025, ASICS Corporation announced a share repurchase program of up to 10 million shares worth ¥30 billion, alongside an increased dividend forecast and raised full-year earnings guidance. This series of shareholder-focused actions highlights ASICS' commitment to returning value to investors and optimizing capital allocation under its Mid-term Management Plan 2026. We’ll explore how the combination of the share buyback and higher earnings outlook influences ASICS’ overall...

On November 11, 2025, Mitsui Kinzoku Company announced increases to both its interim and full-year dividend guidance for the fiscal year ending March 31, 2026, alongside a significant upward revision in earnings forecasts due to strengthened demand and improved market conditions. The company is adopting a progressive dividend policy targeting a dividend on equity of about 3.5%, reflecting its reinforced confidence in sustained profitability and growth within engineered materials and metals...

Monex Group recently reported earnings for the half year ended September 30, 2025, with revenue reaching ¥44,435 million and net income at ¥4,549 million, alongside an increase in its second-quarter dividend to ¥15.30 per share and updated full-year dividend guidance. This marks a slight uptick in returns to shareholders, suggesting the company’s willingness to share improved performance directly with investors. We’ll explore how Monex Group’s higher dividend guidance and earnings results...

Morinaga&Co., Ltd. ( TSE:2201 ) announced strong profits, but the stock was stagnant. Our analysis suggests that this...

Investors were underwhelmed by the solid earnings posted by Ahresty Corporation ( TSE:5852 ) recently. We did some...

Riskmonster.com's ( TSE:3768 ) robust earnings report didn't manage to move the market for its stock. Our analysis...

Nippon Express Holdings (TSE:9147) has just wrapped up a major share buyback and is now weighing the retirement of some of its treasury stock in an upcoming board meeting. These steps can draw attention from value-focused investors. See our latest analysis for Nippon Express Holdings. The upbeat tone from Nippon Express Holdings’ sizable buyback is apparent when you look at its performance, with a running year-to-date share price return of 32.5% and a strong 12-month total shareholder return...

On November 9, 2025, Otsuka Pharmaceutical reported 12-month interim results from its Phase 3 VISIONARY trial of sibeprenlimab for IgA nephropathy at the American Society of Nephrology Kidney Week, with summary data published in The New England Journal of Medicine. The interim analysis showed sibeprenlimab achieved a substantial reduction in proteinuria versus placebo, supporting Otsuka's recent U.S. FDA Priority Review and highlighting its innovative approach to tackling a rare kidney...

Nippon Kayaku Co., Ltd.'s ( TSE:4272 ) stock was strong after they recently reported robust earnings. However, our...

Hyakujushi Bank (TSE:8386) made a splash by rolling out several shareholder-focused moves at once, including boosting its full-year earnings guidance, raising dividend forecasts, and announcing a share repurchase program. See our latest analysis for Hyakujushi Bank. Hyakujushi Bank’s recent series of shareholder-friendly announcements comes alongside strong share price momentum, with a year-to-date return of 74.5% and a 1-year total shareholder return of nearly 98%. Investors appear to be...

Chugai Pharmaceutical's (TSE:4519) stock is up by a considerable 30% over the past three months. Given that the market...